Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Collegium Pharmaceutical Inc
COLLCurrent price
33.35 USD
-0.11 USD (-0.33%)
Last closed
33.46 USD
Company
www.collegiumpharma.com
ISIN
US19459J1043
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
990 726 144 USD
Yield for 12 month
-0.48 %
1Y
3Y
5Y
10Y
15Y
COLL
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
42.25 USDP/E ratio
13.13Dividend Yield
–Current Year
+566 767 000 USD
Last Year
+463 933 000 USD
Current Quarter
+159 301 000 USD
Last Quarter
+145 276 000 USD
Current Year
+326 169 000 USD
Last Year
+209 488 000 USD
Current Quarter
+96 794 000 USD
Last Quarter
+90 806 000 USD
Key Figures COLL
1 year
3 years
5 years
10 years
EBITDA
365 820 992 USD
Operating Margin TTM
PE Ratio
13.13
Return On Assets TTM
9.68 %
PEG Ratio
–
Return On Equity TTM
42.89 %
Wall Street Target Price
42.25 USD
Revenue TTM
599 244 992 USD
Book Value
7.27 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
16.50 %
Dividend Yield
–
Gross Profit TTM
345 743 000 USD
Earnings per share
2.34 USD
Diluted Eps TTM
2.34 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-49.50 %
Profit Margin
14.78 %
Dividend Analytics COLL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History COLL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation COLL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
13.13
Forward PE
4.85
Enterprise Value Revenue
2.91
Price Sales TTM
1.65
Enterprise Value EBITDA
5.03
Price Book MRQ
4.23
Financials COLL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators COLL
For 52 weeks
28.97 USD
42.29 USD
50 Day MA
33.46 USD
Shares Short Prior Month
6 285 123
200 Day MA
35.13 USD
Short Ratio
12.65
Shares Short
6 108 028
Short Percent
23.48 %
BeatStart